Figure 8.
Differences in the expressions of marker genes for immune checkpoint inhibitors between low- and high-risk patients. (A) CD274 (PD-L1); (B) CD28; (C) TGFBR1; (D) TNFSF4 (OX40L). *P < 0.05, **P < 0.01, ***P < 0.001.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.